HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 45658,
"recordsTotal": 45658,
"next": "http://staging-fdaaa.ebmdatalab.net/api/trials/?format=api&length=300&ordering=registry_id&start=42600",
"previous": "http://staging-fdaaa.ebmdatalab.net/api/trials/?format=api&length=300&ordering=registry_id&start=42000",
"results": [
{
"registry_id": "NCT05909358",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05909358",
"title": "A Phase I/II Randomized Placebo Controlled Trial to Evaluate the Safety and Immunogenicity of Sudan Ebolavirus Vaccines in Uganda",
"has_exemption": false,
"start_date": "2023-07-31",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Makerere University",
"sponsor_slug": "makerere-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04419272",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04419272",
"title": "Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits: a Randomized, Double-blind, Placebo-controlled Trial",
"has_exemption": false,
"start_date": "2023-08-14",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06059690",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06059690",
"title": "Biologic Association Between Metabolic MR-PET and Tissue Measures of Glycolysis in Brain Tumors Visualization, Quantitation, and Targeting of Infiltrating Glioblastoma Cells with PH Sensitive Amine Chemical Exchange Saturation Transfer Magnetic Resonance Imaging-KL2TR001882",
"has_exemption": false,
"start_date": "2023-09-06",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05979441",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05979441",
"title": "A Phase 3, Single-Arm, Multicenter, Open-label Extension of Study ARGX-113-2007 to Investigate the Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Participants Aged 18 Years and Older With Active Idiopathic Inflammatory Myopathy",
"has_exemption": false,
"start_date": "2023-09-12",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "argenx",
"sponsor_slug": "argenx",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06042517",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06042517",
"title": "Mechanisms of Ultrasound Neuromodulation Effects in Diabetes",
"has_exemption": false,
"start_date": "2023-09-30",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05949021",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05949021",
"title": "OCTANE: Adjuvant Liposomal Doxorubicin and Carboplatin for Early-stage Triple Negative Breast Cancer",
"has_exemption": false,
"start_date": "2023-10-07",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Mridula George, MD",
"sponsor_slug": "mridula-george-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05583721",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05583721",
"title": "An Evaluation of the Relationship Between Abnormal Myocardial Perfusion and Diastolic Dysfunction in Sickle Cell Disease Using PET (Stress-Rest) Myocardial Perfusion Imaging (MYPERS)",
"has_exemption": false,
"start_date": "2023-10-10",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06042153",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06042153",
"title": "Semaglutide for Dialysis-Treated Patients - a Glucose Time in Range Study- DIALYSIS-TIR Study",
"has_exemption": false,
"start_date": "2023-12-05",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05769153",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05769153",
"title": "A Phase 1/2 Two-Stage Dose Escalation and Randomized Parallel-Group Study to Evaluate the Safety, Preliminary Treatment Effects, and Durability of AR-14034 Sustained Release Implant Compared to Intravitreal Anti-Vascular Endothelial Growth Factor Treatment in Participants With Neovascular Age-Related Macular Degeneration",
"has_exemption": false,
"start_date": "2023-12-06",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Alcon Research",
"sponsor_slug": "alcon-research",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06141031",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06141031",
"title": "Phase I/IB Trial of Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma",
"has_exemption": false,
"start_date": "2024-01-16",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05828823",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05828823",
"title": "Comparative Effectiveness of an Individualized Model of Hemodialysis Versus Conventional Hemodialysis",
"has_exemption": false,
"start_date": "2024-02-26",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05494398",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05494398",
"title": "Targeting the Neurobiology of Restricted and Repetitive Behaviors in Children With Autism Using N-acetylcysteine: an Open Label Extension",
"has_exemption": false,
"start_date": "2024-03-12",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05612594",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05612594",
"title": "Adipose Dysfunction, Imaging, Physiology, and Outcomes With SGLT2i's for Sleep Apnea: The ADIPOSA Study",
"has_exemption": false,
"start_date": "2024-03-27",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06345339",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06345339",
"title": "A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism",
"has_exemption": false,
"start_date": "2024-04-26",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06282965",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06282965",
"title": "A Randomized, Double-blind, Placebo Controlled Study of the Safety and Efficacy of Angiotensin (1-7) in Persons With Moderate to Severe Traumatic Brain Injury (TBI)",
"has_exemption": false,
"start_date": "2024-05-28",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Arizona",
"sponsor_slug": "university-of-arizona",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06423300",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06423300",
"title": "Evaluation of the Patellar LIFT System for Subjects with Patellofemoral Cartilage Degeneration",
"has_exemption": false,
"start_date": "2024-06-19",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "ZKR Orthopedics Inc",
"sponsor_slug": "zkr-orthopedics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06540833",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06540833",
"title": "A Multicenter, Randomized, Double-blind, Placebo-controlled, Flexible-dose Study to Assess the Efficacy, Safety, and Tolerability of ITI-1284 in Patients With Psychosis Associated With Alzheimer's Disease",
"has_exemption": false,
"start_date": "2024-08-15",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Intra-Cellular Therapies, Inc.",
"sponsor_slug": "intra-cellular-therapies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06503731",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06503731",
"title": "A Global, Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study to Evaluate the Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC Administered by a Prefilled Syringe in Kidney Transplant Recipients With Antibody-Mediated Rejection",
"has_exemption": false,
"start_date": "2024-08-30",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "argenx",
"sponsor_slug": "argenx",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06640998",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06640998",
"title": "Clinical Study to Evaluate the Safety and Efficacy of Matrix Pro Applicator Treatment to Lift the Eyebrow and Lift Lax Tissue in the Submentum and Neck",
"has_exemption": false,
"start_date": "2024-09-09",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Candela Corporation",
"sponsor_slug": "candela-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06525298",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06525298",
"title": "A Phase 1/2, Open Label Trial to Investigate the Safety, Tolerability, and Preliminary Efficacy of EIS-12656 as Single Agent and in Combination With a Poly-ADP Ribose Polymerase (PARP) Inhibitor or Trastuzumab Deruxtecan (T-DXd), an Antibody Drug Conjugate (ADC), in Participants With Specified Solid Tumors",
"has_exemption": false,
"start_date": "2024-09-09",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eisbach Bio GmbH",
"sponsor_slug": "eisbach-bio-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06594991",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06594991",
"title": "A Phase 2 Study of Fianlimab, Cemiplimab, and Ipilimumab in Anti-PD-1 Refractory Melanoma",
"has_exemption": false,
"start_date": "2024-09-10",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06620705",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06620705",
"title": "Pacing Away from Heart Failure: Left Bundle Branch Area Pacing or Biventricular Pacing in Patients with Atrial Fibrillation and Left Ventricular Dysfunction",
"has_exemption": false,
"start_date": "2024-09-10",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "srdpiers",
"sponsor_slug": "srdpiers",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06976671",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06976671",
"title": "A Phase II Proof-of-concept Study Evaluating the Safety and Efficacy of Bevacizumab in the Treatment of Adhesive Capsulitis",
"has_exemption": false,
"start_date": "2024-09-10",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Macquarie University, Australia",
"sponsor_slug": "macquarie-university-australia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06730841",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06730841",
"title": "Dose-Optimized and Spaced Transcranial Direct Current Stimulation for Treatment-Resistant Depression",
"has_exemption": false,
"start_date": "2024-09-26",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06518837",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06518837",
"title": "FITWISE: Feasibility Study of Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer",
"has_exemption": false,
"start_date": "2024-10-30",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rutgers, The State University of New Jersey",
"sponsor_slug": "rutgers-the-state-university-of-new-jersey",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06589440",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06589440",
"title": "Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)",
"has_exemption": false,
"start_date": "2024-11-20",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stingray Therapeutics",
"sponsor_slug": "stingray-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06460506",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06460506",
"title": "A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Subjects 12 Months of Age and Older",
"has_exemption": false,
"start_date": "2024-11-21",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vertex Pharmaceuticals Incorporated",
"sponsor_slug": "vertex-pharmaceuticals-incorporated",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06684509",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06684509",
"title": "Using of Atorvastatin for Anthracyclin _ Associated Cardiotoxicity in Hemetological Malignancies Patients.",
"has_exemption": false,
"start_date": "2024-11-30",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Assiut University",
"sponsor_slug": "assiut-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06384222",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06384222",
"title": "Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) As a Response Monitoring Tool in Patients with High-Risk Prostate Cancer Receiving Neoadjuvant Therapy",
"has_exemption": false,
"start_date": "2024-12-09",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Ivan de Kouchkovsky, MD",
"sponsor_slug": "ivan-de-kouchkovsky-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06501872",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06501872",
"title": "Safety and Effectiveness of Physician-Modified Fenestrated and Branched Aortic Endografting for the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms",
"has_exemption": false,
"start_date": "2024-12-10",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Bjoern D. Suckow",
"sponsor_slug": "bjoern-d-suckow",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06736574",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06736574",
"title": "A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial to Assess Efficacy and Safety of Omecamtiv Mecarbil in Patients With Symptomatic Heart Failure With Severely Reduced Ejection Fraction (COMET-HF)",
"has_exemption": false,
"start_date": "2024-12-19",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Cytokinetics",
"sponsor_slug": "cytokinetics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06679985",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06679985",
"title": "A Randomized Phase 2 Study of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma",
"has_exemption": false,
"start_date": "2024-12-20",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Coherus Biosciences, Inc.",
"sponsor_slug": "coherus-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06266364",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06266364",
"title": "Targeted Plasticity Therapy for the Treatment of Post-Traumatic Stress Disorder",
"has_exemption": false,
"start_date": "2024-12-30",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas at Dallas",
"sponsor_slug": "the-university-of-texas-at-dallas",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06660654",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06660654",
"title": "REJOICE-PanTumor01: A Phase 2, Multicenter, Open-Label, Pan-Tumor Trial to Evaluate Efficacy and Safety of Raludotatug Deruxtecan (R-DXd) in Participants With Advanced/Metastatic Solid Tumors",
"has_exemption": false,
"start_date": "2025-01-06",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06754462",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06754462",
"title": "A Phase 2b, Multicenter, Double-blind, Placebo-controlled Randomized Withdrawal Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat, ACPA-Positive Rheumatoid Arthritis",
"has_exemption": false,
"start_date": "2025-01-10",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Immunovant Sciences GmbH",
"sponsor_slug": "immunovant-sciences-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06823778",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06823778",
"title": "Prophylactic Radiofrequency Left Atrial Posterior Wall Isolation (box Lesion Ablation) to Prevent Atrial Fibrillation After Cardiac Surgery (PROBOX): a Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-02-17",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vasily I. Kaleda",
"sponsor_slug": "vasily-i-kaleda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06639984",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06639984",
"title": "Assessing Psyllium Given With Meals for Fructan Sensitivity in Children With Irritable Bowel Syndrome",
"has_exemption": false,
"start_date": "2025-02-20",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Dr Bruno Chumpitazi, M.D.",
"sponsor_slug": "dr-bruno-chumpitazi-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06773416",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06773416",
"title": "Treating Sleep Apnea to Improve Cognitive Function, Alzheimer's Disease Pathology, and Astrocyte Activation in Older Adults With Cognitive Impairment: A Multi-Centre Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-02-28",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sunnybrook Health Sciences Centre",
"sponsor_slug": "sunnybrook-health-sciences-centre",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06892639",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06892639",
"title": "Evaluation of Dabocemagene Autoficel (D-Fi; FCX-007; Genetically Modified Autologous Human Dermal Fibroblasts) for the Treatment of Wounds Due to Dystropic Epidermolysis Bullosa",
"has_exemption": false,
"start_date": "2025-03-27",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Castle Creek Biosciences, LLC.",
"sponsor_slug": "castle-creek-biosciences-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06908733",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06908733",
"title": "Prognosis and Patient-Reported Outcomes of Combined Local Treatments (Surgery and Radiotherapy or Radiotherapy Alone) With Tislelizumab and Chemotherapy in Initial Stage III-N3 Non-Small Cell Lung Cancer: A Prospective, Open-Label, Single-Arm, Phase II Trial",
"has_exemption": false,
"start_date": "2025-03-31",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Liaoning Cancer Hospital & Institute",
"sponsor_slug": "liaoning-cancer-hospital-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06881992",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06881992",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ersodetug in Patients With Inadequately Controlled Hypoglycemia Due to Tumor-Associated Hyperinsulinism (tHI)",
"has_exemption": false,
"start_date": "2025-04-16",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rezolute",
"sponsor_slug": "rezolute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06948435",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06948435",
"title": "A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Once Daily in Participants With Hypertension and Obesity or Overweight: Randomized, Double-Blind, Placebo-Controlled Trials (ATTAIN-HYPERTENSION)",
"has_exemption": false,
"start_date": "2025-04-30",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06948422",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06948422",
"title": "A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Once Daily in Participants With Hypertension and Obesity or Overweight: Randomized, Double-Blind, Placebo-Controlled Trials (ATTAIN-HYPERTENSION)",
"has_exemption": false,
"start_date": "2025-04-30",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06952530",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06952530",
"title": "A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Once Daily in Participants With Hypertension and Obesity or Overweight: Randomized, Double-Blind, Placebo-Controlled Trials (ATTAIN-HYPERTENSION)",
"has_exemption": false,
"start_date": "2025-04-30",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06925750",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06925750",
"title": "An Open-label Extension Study to Evaluate Safety and Tolerability of Sotatercept (MK-7962) Administered Using a Weight-banded Approach in Participants With Pulmonary Arterial Hypertension (PAH) on Standard of Care",
"has_exemption": false,
"start_date": "2025-05-12",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06966479",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06966479",
"title": "A Long-Term Extension Study to Evaluate Safety and Efficacy of Verekitug (UPB-101) in Adult Participants With Severe Asthma Who Completed the VALIANT Trial",
"has_exemption": false,
"start_date": "2025-05-21",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Upstream Bio Inc.",
"sponsor_slug": "upstream-bio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07035093",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07035093",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly in Participants Who Have Obesity or Overweight and Chronic Low Back Pain",
"has_exemption": false,
"start_date": "2025-05-29",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06521723",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06521723",
"title": "Breathing Low Oxygen to Enhance Spinal Stimulation Training and Functional Recovery for Aging Adults With Chronic SCI: The BO2ST-II Trial",
"has_exemption": false,
"start_date": "2025-05-31",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Spaulding Rehabilitation Hospital",
"sponsor_slug": "spaulding-rehabilitation-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06868485",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06868485",
"title": "A Phase II, Open Label, Multicenter, Single Arm Study of WSD0922-FU for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer with First-Line Osimertinib Treatment and Harbor a C797S Mutation",
"has_exemption": false,
"start_date": "2025-05-31",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Wayshine Biopharm, Inc.",
"sponsor_slug": "wayshine-biopharm-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06333171",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06333171",
"title": "4-aminopyridine for Skin Wound Healing",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "John Elfar",
"sponsor_slug": "john-elfar",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06722183",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06722183",
"title": "FUTURE Platform Trial - A Phase II Platform Trial of Futibatinib in Combination With (Chemo)Immunotherapy in Colorectal Cancer and Other Solid Tumor Entities",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest",
"sponsor_slug": "institut-fur-klinische-krebsforschung-ikf-gmbh-at-krankenhaus-nordwest",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06891755",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06891755",
"title": "Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3",
"has_exemption": false,
"start_date": "2025-07-15",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Apreo Health, Inc.",
"sponsor_slug": "apreo-health-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06779630",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06779630",
"title": "BIOTRONIK - A Prospective Multicenter Single Arm Study to Assess the SaFety and Effectiveness of the Orsiro Mission 48-mm SiroLimus-Eluting Coronary Stent System for the Treatment Of Subjects With Atherosclerotic Lesion(s)",
"has_exemption": false,
"start_date": "2025-07-18",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Biotronik, Inc.",
"sponsor_slug": "biotronik-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07089888",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07089888",
"title": "A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Dotinurad Compared With Allopurinol in Adult Participants With Tophaceous Gout",
"has_exemption": false,
"start_date": "2025-07-30",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Crystalys Therapeutics",
"sponsor_slug": "crystalys-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06979076",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06979076",
"title": "A Phase Ib Study of the Selective PKC-β Inhibitor MS-553 in Patients With Refractory or Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "MingSight Pharmaceuticals, Inc.",
"sponsor_slug": "mingsight-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07053969",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07053969",
"title": "The Effect Of Enamel Matrix Protein On Gingival Tissue Thickness. A Randomized Controlled Trial.",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center at San Antonio",
"sponsor_slug": "the-university-of-texas-health-science-center-at-san-antonio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06990269",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06990269",
"title": "A Phase 2, Randomized, Masked, Placebo-Controlled Study of Subcutaneously Administered ADX-038 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "ADARx Pharmaceuticals, Inc.",
"sponsor_slug": "adarx-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07084909",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07084909",
"title": "Phase 2/3 Open-Label Multicenter Study to Assess the Diagnostic Performance of Piflufolastat F 18 PET/CT on Intended Clinical Management in Patients With Suspected, or at High Risk for Metastatic ccRCC",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Lantheus Medical Imaging",
"sponsor_slug": "lantheus-medical-imaging",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04752319",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04752319",
"title": "BreEStim for Post-Stroke Motor Recovery",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06029062",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06029062",
"title": "tACS Brain Neuromodulation for Sensory and Motor Recovery After Neurological Impairments",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06029075",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06029075",
"title": "tACS Brain Neuromodulation for Sensory and Motor Recovery After Neurological Impairments",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06072326",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06072326",
"title": "Individual and Combined Endothelin Receptor and SGLT1/2 Antagonism in Adults With Type 1 Diabetes Mellitus and Chronic Kidney Disease: a Phase 2, Multicenter, Open-label Randomized Cross-over Trial",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University Medical Center Groningen",
"sponsor_slug": "university-medical-center-groningen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07090616",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07090616",
"title": "A Randomized Controlled Trial of the KRONOS Versus Breg T-Scope Post-operative Knee Braces Following Anterior Cruciate Ligament (ACL) Reconstruction",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rush University Medical Center",
"sponsor_slug": "rush-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07010614",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07010614",
"title": "Theta Burst Modulation of Hippocampal-Cortical Rhythms in Schizophrenia",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07077278",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07077278",
"title": "Effect of Low Sodium Oxybate (LXB) on Autonomic Symptom Burden in Idiopathic Hypersomnia Patients With Postural Tachycardia Syndrome: a Placebo-controlled, Double-blind, Randomized Withdrawal Study",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05237687",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05237687",
"title": "Sirolimus in Older Adults- Randomized Trial Assessing the Improvement in Phenotypic/Functional Biomarkers of Aging",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Irina Timofte",
"sponsor_slug": "irina-timofte",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06956014",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06956014",
"title": "Multicenter, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of the Full-spectrum Cannabis Extract VER-01 in Patients With Chronic Low Back Pain",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vertanical GmbH",
"sponsor_slug": "vertanical-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05731050",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05731050",
"title": "A Phase II, Open Label, Multi Dose Study of NM8074 in Soliris-Treated Subjects With Paroxysmal Nocturnal Hemoglobinuria (PNH)",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "NovelMed Therapeutics",
"sponsor_slug": "novelmed-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03674697",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03674697",
"title": "The Effect of Light Therapy on Post-Surgical Pain",
"has_exemption": false,
"start_date": "2018-09-05",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Arizona",
"sponsor_slug": "university-of-arizona",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04025372",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04025372",
"title": "INTREPId (INTermediate Risk Erection PreservatIon Trial): A Randomized Trial of Radiation Therapy and Darolutamide for Prostate Cancer",
"has_exemption": false,
"start_date": "2020-06-01",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Dana-Farber Cancer Institute",
"sponsor_slug": "dana-farber-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05070845",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05070845",
"title": "AN INTERVENTIONAL PHASE 2, OPEN-LABEL, MULTI-CENTER STUDY TO EVALUATE SAFETY AND EFFICACY OF PF-06835375 IN ADULT PARTICIPANTS WITH MODERATE TO SEVERE PRIMARY IMMUNE THROMBOCYTOPENIA",
"has_exemption": false,
"start_date": "2022-02-02",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05415072",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05415072",
"title": "A Phase I/II, Multi-center, Open Label Study of DYP688 in Patients With Metastatic Uveal Melanoma (MUM) and Other GNAQ/11 Mutant Melanomas",
"has_exemption": false,
"start_date": "2022-07-04",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05068232",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05068232",
"title": "A Phase II Trial of Durvalumab and Ablative Radiation in Extensive-Stage Small Cell Lung Cancer (DARES)",
"has_exemption": false,
"start_date": "2022-08-19",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05531084",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05531084",
"title": "Safety and Effectiveness of Surgeon-Modified Fenestrated and Branched Endografts in Treating Subjects With Complex Aortic Aneurysms",
"has_exemption": false,
"start_date": "2022-10-01",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jesse Manunga, MD",
"sponsor_slug": "jesse-manunga-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05317936",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05317936",
"title": "Pirtobrutinib (LOXO-305) Consolidation for MRD Eradication in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL) Treated With Venetoclax",
"has_exemption": false,
"start_date": "2022-11-16",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05819138",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05819138",
"title": "Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes",
"has_exemption": false,
"start_date": "2023-06-21",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05950945",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05950945",
"title": "A Phase 3b, Multicenter, Global, Interventional, Open-label Study of Trastuzumab Deruxtecan (T-DXd), an Anti-HER2-Antibody Drug Conjugate (ADC), in Subjects Who Have Unresectable and/or Metastatic HER2-low or HER2 Immunohistochemistry (IHC) 0 Breast Cancer (DESTINY-Breast15)",
"has_exemption": false,
"start_date": "2023-12-30",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05849298",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05849298",
"title": "An International Prospective Open-label, Multi-center, Randomized, Non-comparative Phase II Study of Lutetium [177Lu] Vipivotide Tetraxetan (AAA617) Alone and Lutetium [177Lu] Vipivotide Tetraxetan (AAA617) in Combination With Androgen Receptor Pathway Inhibitors in Patients With PSMA PET Scan Positive Castration-Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2024-01-03",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06235801",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06235801",
"title": "A Phase I/II Study of Gilteritinib and Momelotinib for Patients With Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2024-05-22",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06449326",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06449326",
"title": "Multimodal Image Analysis and Guidance of Neuromodulation for Trauma-Related Symptoms",
"has_exemption": false,
"start_date": "2024-06-01",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of New Mexico",
"sponsor_slug": "university-of-new-mexico",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06891807",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06891807",
"title": "RobAR Study: Comparison of Image Based Robotic TKA vs Imageless Augmented Reality-Assisted TKA",
"has_exemption": false,
"start_date": "2024-07-18",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medisch Centrum Latem",
"sponsor_slug": "medisch-centrum-latem",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06668194",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06668194",
"title": "A Randomized Clinical Trial Comparing the Effect of Force Magnitude on the Rate of Canine Retraction and Gingival Crevicular Fluid Proteome Profile",
"has_exemption": false,
"start_date": "2024-11-13",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "UConn Health",
"sponsor_slug": "uconn-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06526104",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06526104",
"title": "Phase II Single Arm Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas with Child-Pugh-B Cirrhosis (STRIDE in CP-B)",
"has_exemption": false,
"start_date": "2024-12-02",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center at San Antonio",
"sponsor_slug": "the-university-of-texas-health-science-center-at-san-antonio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06692452",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06692452",
"title": "A Phase II Study of Tazemetostat in Combination With CHOP for Previously Untreated T Cell Lymphoma",
"has_exemption": false,
"start_date": "2024-12-24",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Eric Jacobsen, MD",
"sponsor_slug": "eric-jacobsen-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05726292",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05726292",
"title": "A Randomized Phase II Trial of Neoadjuvant Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer",
"has_exemption": false,
"start_date": "2025-01-06",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06581328",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06581328",
"title": "A Phase 4 Study Evaluating Moderate to Severely Active Ulcerative Colitis or Crohn's Disease and the Use of Vedolizumab Subcutaneous Within a Community Setting",
"has_exemption": false,
"start_date": "2025-03-27",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06195306",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06195306",
"title": "Phase 2 Study of Low Dose Tamoxifen +/- High Dose Omega-3 Fatty Acids in Overweight Postmenopausal Women at Increased Risk for Breast Cancer",
"has_exemption": false,
"start_date": "2025-04-01",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06041503",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06041503",
"title": "A Phase II Multicenter Study of Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE)",
"has_exemption": false,
"start_date": "2025-08-06",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06997198",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06997198",
"title": "Identification, Assessment, and Treatment of Tardive Dyskinesia With Deutetrabenazine in Adults With Intellectual/Developmental Disabilities and Co-occurring Psychiatric and/or Behavioral Disorders",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University Hospitals Cleveland Medical Center",
"sponsor_slug": "university-hospitals-cleveland-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06735820",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06735820",
"title": "Early Phase Study to Evaluate the MEK Inhibitor Selumetinib With the MDM2 Inhibitor APG-115 in Patients With Neurofibromatosis Type 1 and Pre-malignant and Malignant Peripheral Nerve Sheath Tumors",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "AeRang Kim",
"sponsor_slug": "aerang-kim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06941415",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06941415",
"title": "Bumetanide vs. Furosemide for Adults Hospitalized With Cirrhosis: the BUFF Trial",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Stacy Johnson",
"sponsor_slug": "stacy-johnson",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06961383",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06961383",
"title": "A Double Blind, Randomized, Placebo Controlled Phase 2b Study to Evaluate the Safety and Clinical Efficacy of Treatment With the Autologous Cell Therapy Product, NG01, in Patients With Secondary Progressive Multiple Sclerosis",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "NeuroGenesis Ltd.",
"sponsor_slug": "neurogenesis-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07049458",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07049458",
"title": "A Phase I/IIa, Open-Label, Dose-Escalation and Cohort-Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of CHO-A04 in Subjects With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Cho Pharma Inc.",
"sponsor_slug": "cho-pharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04871607",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04871607",
"title": "A Phase 2 Trial of Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy (aTac-BEAM) Conditioning for Autologous Hematopoietic Cell Transplantation (AHCT) in Patients With Primary Refractory or Relapsed Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2021-11-02",
"completion_date": "2027-10-02",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06810934",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06810934",
"title": "A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2027-10-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Kara Chew",
"sponsor_slug": "kara-chew",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05404945",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05404945",
"title": "Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and Above (cHL 001)",
"has_exemption": false,
"start_date": "2022-07-26",
"completion_date": "2027-10-03",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Virginia",
"sponsor_slug": "university-of-virginia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06562543",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06562543",
"title": "A Single Arm Phase 4 Trial to Evaluate the Safety and Efficacy of Oral Fruquintinib in the Treatment of Refractory Metastatic Colorectal Cancer in Patients From Minority Populations Underrepresented in Prior Fruquintinib Studies",
"has_exemption": false,
"start_date": "2025-01-14",
"completion_date": "2027-10-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07091630",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07091630",
"title": "A Phase 3, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating the Efficacy and Safety of Empasiprubart IV in Adults With Chronic Inflammatory Demyelinating Polyneuropathy",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2027-10-07",
"has_results": false,
"results_due": false,
"sponsor_name": "argenx",
"sponsor_slug": "argenx",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06524960",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06524960",
"title": "A Phase 1/2 Prospective, Randomized, Double-blind, Placebo-controlled Multi-center Clinical Trial to Determine the Safety and Efficacy of Denosumab in Improving Beta Cell Function and Glycemic Control Among Patients With Type 1 Diabetes",
"has_exemption": false,
"start_date": "2024-09-03",
"completion_date": "2027-10-11",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06504459",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06504459",
"title": "A Phase II Study of Venetoclax (ABT-199) in Combination With Cladribine and Low-Dose Cytarabine Alternating With Azacitidine Plus Venetoclax in Newly Diagnosed Monocytic AML and Active-Signaling Mutated AML",
"has_exemption": false,
"start_date": "2025-01-03",
"completion_date": "2027-10-11",
"has_results": false,
"results_due": false,
"sponsor_name": "OHSU Knight Cancer Institute",
"sponsor_slug": "ohsu-knight-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06744647",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06744647",
"title": "A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of ALXN2030 in Adult Patients With Antibody-Mediated Rejection After Kidney Transplantation",
"has_exemption": false,
"start_date": "2025-03-07",
"completion_date": "2027-10-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Alexion Pharmaceuticals, Inc.",
"sponsor_slug": "alexion-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06676319",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06676319",
"title": "A Randomized, Phase 2, Double-blind, Placebo-controlled, Parallel-group, 2-arm Study to Investigate the Efficacy, Safety, and Tolerability of Subcutaneous Lunsekimig (SAR443765) in Adult Participants With High-risk Asthma Who Are Not Currently Eligible for Biologic Treatment",
"has_exemption": false,
"start_date": "2024-11-07",
"completion_date": "2027-10-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05030428",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05030428",
"title": "A Randomized, Double-blind, Placebo-controlled, Multicenter Trial, Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Participants With Established Cardiovascular Disease (VICTORION-2 PREVENT)",
"has_exemption": false,
"start_date": "2021-11-23",
"completion_date": "2027-10-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06307665",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06307665",
"title": "A Randomized, Double-blind, Multicenter, Parallel-group, Phase IIIb 52 Week Study Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered as Needed in Participants 12 to < 18 Years of Age With Asthma (ACADIA)",
"has_exemption": false,
"start_date": "2024-05-20",
"completion_date": "2027-10-13",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04776252",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04776252",
"title": "A Phase 3 Open-label Rollover Clinical Study of Doravirine/Islatravir (DOR/ISL) Once-daily for the Treatment of HIV-1 Infection in Participants Who Previously Received DOR/ISL in a Phase 2 or Phase 3 DOR/ISL Clinical Study",
"has_exemption": false,
"start_date": "2021-09-15",
"completion_date": "2027-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05077735",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05077735",
"title": "Stereotactic Biopsy Split-Course Radiation Therapy - Diffuse Midline Glioma (SPORT-DMG)",
"has_exemption": false,
"start_date": "2021-10-11",
"completion_date": "2027-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05465954",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05465954",
"title": "Efficacy and Safety Study of Neoadjuvant Efineptakin Alfa (NT-I7) and Pembrolizumab in Recurrent Glioblastoma",
"has_exemption": false,
"start_date": "2023-01-24",
"completion_date": "2027-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05922930",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05922930",
"title": "Phase I/II Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer",
"has_exemption": false,
"start_date": "2023-10-11",
"completion_date": "2027-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06476704",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06476704",
"title": "Phase 2 Study of Preoperative RAdiation Therapy With Concomitant Liposomal Transcrocetin (L-TC) in Soft tISsue Sarcomas",
"has_exemption": false,
"start_date": "2025-06-01",
"completion_date": "2027-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Institut de Cancerologie Strasbourg Europe",
"sponsor_slug": "institut-de-cancerologie-strasbourg-europe",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07044336",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07044336",
"title": "Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4 Selected Advanced/Metastatic Endometrial Cancer Who Progressed On or After Platinum Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (Bluestar-Endometrial01)",
"has_exemption": false,
"start_date": "2025-07-16",
"completion_date": "2027-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06202066",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06202066",
"title": "A Phase II Study of Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) in Patients With Progressing Metastatic Neuroendocrine Tumors (NETs)",
"has_exemption": false,
"start_date": "2025-08-15",
"completion_date": "2027-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Roswell Park Cancer Institute",
"sponsor_slug": "roswell-park-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06112314",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06112314",
"title": "A Phase 3 Randomized, Controlled Study of IMC-F106C Plus Nivolumab Versus Nivolumab Regimens in HLA-A*02:01-Positive Participants With Previously Untreated Advanced Melanoma (PRISM-MEL-301",
"has_exemption": false,
"start_date": "2024-06-05",
"completion_date": "2027-10-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Immunocore Ltd",
"sponsor_slug": "immunocore-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03876769",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03876769",
"title": "A Phase II Trial of Tisagenlecleucel in First-line High-risk (HR) Pediatric and Young Adult Patients With B-cell Acute Lymphoblastic Leukemia (B-ALL) Who Are Minimal Residual Disease (MRD) Positive at the End of Consolidation (EOC) Therapy",
"has_exemption": false,
"start_date": "2019-06-24",
"completion_date": "2027-10-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04747613",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04747613",
"title": "An Open Label, Multicenter Roll-over Extension Program (REP) to Characterize the Long-term Safety and Tolerability of Iptacopan (LNP023) in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Completed PNH Phase 2 and Phase3 Studies With Iptacopan",
"has_exemption": false,
"start_date": "2021-07-27",
"completion_date": "2027-10-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05545826",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05545826",
"title": "Vibrotactile Coordinated Reset: A Treatment for Early Stage Parkinson's Disease",
"has_exemption": false,
"start_date": "2025-04-01",
"completion_date": "2027-10-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07024563",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07024563",
"title": "A Phase 3, Open-Label, Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Ravulizumab in Pediatric Participants (2 to < 18 Years of Age) With Primary Immunoglobulin A Nephropathy (IgAN)",
"has_exemption": false,
"start_date": "2025-06-14",
"completion_date": "2027-10-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Alexion Pharmaceuticals, Inc.",
"sponsor_slug": "alexion-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07044297",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07044297",
"title": "A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of MK-8527 Oral Once-Monthly as HIV-1 Preexposure Prophylaxis",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2027-10-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02861573",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02861573",
"title": "Phase Ib/II Trial of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (mCRPC) (KEYNOTE-365)",
"has_exemption": false,
"start_date": "2016-11-17",
"completion_date": "2027-10-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT05805605",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05805605",
"title": "Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning (RIC) With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases",
"has_exemption": false,
"start_date": "2023-05-01",
"completion_date": "2027-10-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Masonic Cancer Center, University of Minnesota",
"sponsor_slug": "masonic-cancer-center-university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06656390",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06656390",
"title": "A First-in-Human, Open-Label, Multi-Center Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ALK201 for Injection in Adult Participants With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2024-10-24",
"completion_date": "2027-10-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Shanghai Allink Biotherapeutics Co., Ltd.",
"sponsor_slug": "shanghai-allink-biotherapeutics-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02332668",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02332668",
"title": "A Phase I/II Study of Pembrolizumab (MK-3475) in Children With Advanced Melanoma or a PD-L1 Positive Advanced, Relapsed or Refractory Solid Tumor or Lymphoma (KEYNOTE-051)",
"has_exemption": false,
"start_date": "2015-03-18",
"completion_date": "2027-10-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06966453",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06966453",
"title": "A Phase 1b/2, Open-Label, Multicohort Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2027-10-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03656536",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03656536",
"title": "A Phase 3, Open-Label, Randomized, Active-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Gemcitabine Plus Cisplatin Chemotherapy in First-Line Treatment of Participants With Unresectable or Metastatic Cholangiocarcinoma With FGFR2 Rearrangement (FIGHT-302)",
"has_exemption": false,
"start_date": "2019-06-03",
"completion_date": "2027-10-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Incyte Corporation",
"sponsor_slug": "incyte-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06435312",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06435312",
"title": "An Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Activity of Zilucoplan in Pediatric Study Participants With Acetylcholine Receptor Antibody Positive Generalized Myasthenia Gravis",
"has_exemption": false,
"start_date": "2024-11-19",
"completion_date": "2027-10-26",
"has_results": false,
"results_due": false,
"sponsor_name": "UCB Biopharma SRL",
"sponsor_slug": "ucb-biopharma-srl",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05923073",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05923073",
"title": "A Phase 3, Multicenter, Randomized, Platform Study of p19 Inhibition of the IL-23 Pathway to Establish Efficacy in Pediatric Crohn's Disease",
"has_exemption": false,
"start_date": "2024-03-13",
"completion_date": "2027-10-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04624204",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04624204",
"title": "A Randomized, Double-blind, Placebo-controlled Phase 3 Study of Pembrolizumab (MK-3475) in Combination With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib (MK-7339), Compared to Concurrent Chemoradiation Therapy Alone in Participants With Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC)",
"has_exemption": false,
"start_date": "2020-12-08",
"completion_date": "2027-10-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06090539",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06090539",
"title": "A Phase 1/2, Multi-Center, Open-Label, Dose-Finding Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of BMS-986458, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed/Refractory Non-Hodgkin Lymphomas (R/R NHL)",
"has_exemption": false,
"start_date": "2023-12-29",
"completion_date": "2027-10-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06293053",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06293053",
"title": "A Multicenter Open-label Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis",
"has_exemption": false,
"start_date": "2024-05-15",
"completion_date": "2027-10-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06959771",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06959771",
"title": "Base Editing Hematopoietic Stem Cell and BE T Cell Gene Therapy for CD40L-HyperIgM Syndrome-Single Patient Study",
"has_exemption": false,
"start_date": "2025-07-16",
"completion_date": "2027-10-28",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02843945",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02843945",
"title": "Initial Feasibility Study to Evaluate the Safety and Efficacy of the Permanently Implantable LDR CivaSheet® in Combination With External Beam Radiation in the Treatment of Pancreatic Cancer",
"has_exemption": false,
"start_date": "2017-05-31",
"completion_date": "2027-10-29",
"has_results": false,
"results_due": false,
"sponsor_name": "CivaTech Oncology",
"sponsor_slug": "civatech-oncology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05584124",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05584124",
"title": "Neuromodulation for Rehabilitation of Post-Stroke Fatigue: An rTMS Pilot Study",
"has_exemption": false,
"start_date": "2023-04-10",
"completion_date": "2027-10-29",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06680661",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06680661",
"title": "ABBA CORD: Double Umbilical Cord Blood Transplants With Abatacept for Graft Versus Host Disease Prophylaxis",
"has_exemption": false,
"start_date": "2025-02-25",
"completion_date": "2027-10-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Leland Metheny",
"sponsor_slug": "leland-metheny",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06117254",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06117254",
"title": "Evaluating Device-based Rehabilitation for Veterans With Functional Hearing Difficulties: A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-03-09",
"completion_date": "2027-10-29",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04752774",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04752774",
"title": "An Integrated Phase I/II, Multicentre, Double-blind, Randomised, Dysport and Placebo-controlled, Dose Escalation and Dose-finding Study to Evaluate the Safety and Efficacy of IPN10200 in the Treatment of Adult Upper Limb Spasticity.",
"has_exemption": false,
"start_date": "2021-04-29",
"completion_date": "2027-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Ipsen",
"sponsor_slug": "ipsen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05018286",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05018286",
"title": "An Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome.",
"has_exemption": false,
"start_date": "2021-07-13",
"completion_date": "2027-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VectivBio AG",
"sponsor_slug": "vectivbio-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05945355",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05945355",
"title": "Mechanistic Study of Inspiratory Training in Childhood Asthma (MICA)",
"has_exemption": false,
"start_date": "2024-08-01",
"completion_date": "2027-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06596135",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06596135",
"title": "Open-Label Extension Study of Setmelanotide in Patients With a Rare Genetic, Syndromic or Acquired Disease of the MC4R Pathway",
"has_exemption": false,
"start_date": "2024-10-21",
"completion_date": "2027-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rhythm Pharmaceuticals, Inc.",
"sponsor_slug": "rhythm-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06220474",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06220474",
"title": "Therapeutic Efficacy and Safety of Non-Invasive Radiofrequency Treatment in Patients With Refractory Meibomian Gland Dysfunction: A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2024-10-22",
"completion_date": "2027-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Hong Kong",
"sponsor_slug": "the-university-of-hong-kong",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06686108",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06686108",
"title": "Safety and Efficacy Study of Demethylating Agents With Venetoclax in Preventing Recurrence of High-risk T-cell Lymphoblastic Lymphoma/Leukemia After Transplantation",
"has_exemption": false,
"start_date": "2024-10-30",
"completion_date": "2027-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine",
"sponsor_slug": "shanghai-general-hospital-shanghai-jiao-tong-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06385262",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06385262",
"title": "Safety, Efficacy, and Tumor Immune Microenvironment Changes With Neoadjuvant Chemotherapy and Cemiplimab With or Without Alirocumab in Stage 1B-3A Non-Small Cell Lung Cancer: TOP 2301",
"has_exemption": false,
"start_date": "2025-03-17",
"completion_date": "2027-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06967558",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06967558",
"title": "The Role of Islet GLP-1 in the Pathogenesis of Prediabetes",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2027-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07043400",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07043400",
"title": "A Phase 3, Multi-Center, Randomized, Open-Label Clinical Study of Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy as First-Line Treatment in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2027-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "BeiGene",
"sponsor_slug": "beigene",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01208389",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01208389",
"title": "A Follow-On Study to Evaluate the Safety of Re-Administration of Adeno-Associated Viral Vector Containing the Gene for Human RPE65 [AAV2-hRPE65v2] to the Contralateral Eye in Subjects With Leber Congenital Amaurosis (LCA) Previously Enrolled in a Phase 1 Study",
"has_exemption": false,
"start_date": "2010-11-30",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Spark Therapeutics, Inc.",
"sponsor_slug": "spark-therapeutics-inc",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02043691",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02043691",
"title": "Evaluation of All-Cause Mortality and Pulmonary Morbidity in Treating Juxtarenal, Suprarenal and Thoracoabdominal Aortic Pathologies Using the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft and Surgeon-Modified Endografts",
"has_exemption": false,
"start_date": "2014-06-30",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03867084",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03867084",
"title": "A Phase 3 Double-blinded, Two-arm Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma and Complete Radiological Response After Surgical Resection or Local Ablation (KEYNOTE-937)",
"has_exemption": false,
"start_date": "2019-05-28",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04133675",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04133675",
"title": "A Single-Blind, Randomized Study of the BTL EmsellaTM Chair Versus Sham for the Treatment of Stress Urinary Incontinence",
"has_exemption": false,
"start_date": "2019-12-18",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "William Beaumont Hospitals",
"sponsor_slug": "william-beaumont-hospitals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03915431",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03915431",
"title": "A Phase 1/2 Randomized Study to Evaluate the Safety and Tolerability of Intracarotid Artery Administration of NCS-01 in Patients With Acute Ischemic Stroke",
"has_exemption": false,
"start_date": "2020-02-27",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "NC Medial Research Inc",
"sponsor_slug": "nc-medial-research-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03603899",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03603899",
"title": "Imaging and Understanding Bronchiolitis Obliterans Syndrome (BOS) in Lung Transplantation With Hyperpolarized 129Xenon MR Lung Imaging",
"has_exemption": false,
"start_date": "2020-09-09",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital Medical Center, Cincinnati",
"sponsor_slug": "childrens-hospital-medical-center-cincinnati",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04563507",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04563507",
"title": "CIMER: Combined Immunotherapies in Metastatic ER+ Breast Cancer",
"has_exemption": false,
"start_date": "2020-11-12",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Weill Medical College of Cornell University",
"sponsor_slug": "weill-medical-college-of-cornell-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04570423",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04570423",
"title": "A Multicenter, Open-Label, Phase 2 Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Patients With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy",
"has_exemption": false,
"start_date": "2021-05-20",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Spectrum Pharmaceuticals, Inc",
"sponsor_slug": "spectrum-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04858334",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04858334",
"title": "APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation",
"has_exemption": false,
"start_date": "2021-06-22",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04851717",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04851717",
"title": "A Phase 2/3, Prospective, Open-label Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of Remimazolam for Intravenous Sedation in Paediatric Patients Undergoing Diagnostic and/or Therapeutic Procedures",
"has_exemption": false,
"start_date": "2021-11-15",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Acacia Pharma Ltd",
"sponsor_slug": "acacia-pharma-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04852328",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04852328",
"title": "Non-Randomized Phase 2 Trial of Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients With Locally Advanced, HPV16-Positive Oropharyngeal Squamous-Cell Carcinoma",
"has_exemption": false,
"start_date": "2021-12-06",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04741646",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04741646",
"title": "Phosphate Binder Therapy and Chronic Kidney Disease in Children",
"has_exemption": false,
"start_date": "2022-06-17",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05312671",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05312671",
"title": "Atezolizumab With Platinum and Etoposide Chemotherapy Followed by Cystectomy for Patients With Localized Small Cell Neuroendocrine Bladder Cancer",
"has_exemption": false,
"start_date": "2022-06-27",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05301816",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05301816",
"title": "A Post-Market, Multicenter, Prospective, Global Clinical Study to Evaluate the Real-world Experience of Spinal Cord Stimulation That Includes 10 kHz in the Management of Chronic Intractable Pain Associated With Diabetic Neuropathy.",
"has_exemption": false,
"start_date": "2022-07-05",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nevro Corp",
"sponsor_slug": "nevro-corp",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05570253",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05570253",
"title": "\"A Phase 2, Double Blinded, Randomized Controlled Trial of Evexomostat (SDX-7320) or Placebo in Combination With Eribulin for Patients With Metastatic Triple-Negative Breast Cancer and Metabolic Dysfunction: The ARETHA Study",
"has_exemption": false,
"start_date": "2022-10-03",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05514054",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05514054",
"title": "EMBER-4: A Randomized, Open-Label, Phase 3 Study of Adjuvant Imlunestrant vs Standard Adjuvant Endocrine Therapy in Patients Who Have Previously Received 2 to 5 Years of Adjuvant Endocrine Therapy for ER+, HER2- Early Breast Cancer With an Increased Risk of Recurrence",
"has_exemption": false,
"start_date": "2022-10-04",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05317806",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05317806",
"title": "Use of Metformin in Prevention and Treatment of Cardiac Fibrosis in PAI-1 Deficient Population",
"has_exemption": false,
"start_date": "2022-10-10",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Indiana Hemophilia &Thrombosis Center, Inc.",
"sponsor_slug": "indiana-hemophilia-thrombosis-center-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05556512",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05556512",
"title": "A Phase 3, Randomized, Double-blind, Placebo-Controlled Study to Investigate the Effect of Tirzepatide on the Reduction of Morbidity and Mortality in Adults With Obesity",
"has_exemption": false,
"start_date": "2022-10-11",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03887481",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03887481",
"title": "Targeting Language-specific and Executive-control Networks With Transcranial Direct Current Stimulation in Aphasic AD (Logopenic Variant PPA)",
"has_exemption": false,
"start_date": "2022-10-15",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05120271",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05120271",
"title": "A First-in-Human, Phase 1/2, Dose Escalation Study of BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors",
"has_exemption": false,
"start_date": "2022-10-26",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sotio Biotech Inc.",
"sponsor_slug": "sotio-biotech-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05256225",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05256225",
"title": "A Phase II/III Study of Paclitaxel/Carboplatin Alone or Combined With Either Trastuzumab and Hyaluronidase-oysk (HERCEPTIN HYLECTA) or Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf (PHESGO) in HER2 Positive, Stage I-IV Endometrial Serous Carcinoma or Carcinosarcoma",
"has_exemption": false,
"start_date": "2022-11-16",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05492799",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05492799",
"title": "Open-Label Multicenter Extension Study to Further Evaluate Safety, Tolerability and Efficacy of Intracerebroventricular AX 250 Treatment in Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B) Patients",
"has_exemption": false,
"start_date": "2022-12-02",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Allievex Corporation",
"sponsor_slug": "allievex-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05650229",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05650229",
"title": "An Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Flexible-dose, Adaptive Study of the Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease",
"has_exemption": false,
"start_date": "2022-12-13",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Abliva AB",
"sponsor_slug": "abliva-ab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02616302",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02616302",
"title": "A Phase 2, Double-Blind, 12-Week, Multicenter Study to Assess the Safety and Effectiveness of Daily Oral Administration of Dexlansoprazole Delayed-Release Capsules in Pediatric Subjects Aged 2 to 11 Years With Symptomatic Nonerosive Gastroesophageal Reflux Disease",
"has_exemption": false,
"start_date": "2023-02-20",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05644496",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05644496",
"title": "A Randomized Controlled Trial of ZYNRELEF Versus Standard of Care for Pain Management Following Unilateral Total Knee Arthroplasty",
"has_exemption": false,
"start_date": "2023-03-09",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Baptist Health South Florida",
"sponsor_slug": "baptist-health-south-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02615184",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02615184",
"title": "A Phase 2, Double-Blind, 36-Week, Multicenter Study to Assess the Safety and Effectiveness of Daily Oral Administration of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis (EE) and Maintenance of Healed EE in Pediatric Subjects Aged 2 to 11 Years With EE",
"has_exemption": false,
"start_date": "2023-05-23",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05564598",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05564598",
"title": "A Phase II Open-Label Randomized Study of Anti-Viral Antibiotic Therapy With and Without Familial (Maternal) Cytomegalovirus (CMV) Cytotoxic T Lymphocytes (CTLs) in Neonates With Moderate/Severe Maternal Acquired CMV Infection",
"has_exemption": false,
"start_date": "2023-07-01",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "New York Medical College",
"sponsor_slug": "new-york-medical-college",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05901675",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05901675",
"title": "Enhancing Mobility and Psychosocial Function in Obese Veterans Following Stroke Via Weight Loss and ExeRcise (EMPOWER)",
"has_exemption": false,
"start_date": "2023-07-07",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05514899",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05514899",
"title": "Effects of Cannabidiol and Tetrahydrocannabinol on the Microbiome, Endocannabinoids, and Neuroinflammation in HIV",
"has_exemption": false,
"start_date": "2023-09-01",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06099769",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06099769",
"title": "A RANDOMIZED, PHASE II STUDY OF ENZALUTAMIDE, ENZALUTAMIDE WITH MIFEPRISTONE, and TREATMENT OF PHYSICIAN'S CHOICE IN PATIENTS WITH AR+ METASTATIC TRIPLE-NEGATIVE OR ER-LOW BREAST CANCER",
"has_exemption": false,
"start_date": "2023-10-18",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05836584",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05836584",
"title": "A Randomized Phase II Study of Perioperative Atezolizumab +/- Chemotherapy in Resectable MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer",
"has_exemption": false,
"start_date": "2023-12-06",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06244771",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06244771",
"title": "An Open-Label, Phase 1/2 Dose Escalation, Dose Expansion and Cohort Expansion Study Evaluating the Safety, PK and Clinical Activity of FMC-376 in Participants With KRAS G12C Mutated Locally Advanced Unresectable or Metastatic Solid Tumors",
"has_exemption": false,
"start_date": "2024-02-12",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Frontier Medicines Corporation",
"sponsor_slug": "frontier-medicines-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05730712",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05730712",
"title": "Phase II Trial of Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf (HP) Plus Enzalutamide for the Treatment of Selected Patients With Metastatic Castration-Resistant Prostate Cancer (TraPPer)",
"has_exemption": false,
"start_date": "2024-03-08",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06214065",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06214065",
"title": "Modulating Temporoparietal Junction Mentalizing-Related Activity in Autism Spectrum Disorder Using Transcranial Magnetic Stimulation",
"has_exemption": false,
"start_date": "2024-04-03",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06203600",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06203600",
"title": "Randomized Phase II/III Trial of 2nd Line Nivolumab + Paclitaxel + Ramucirumab Versus Paclitaxel + Ramucirumab in Patients With PD-L1 CPS >/= 1 Advanced Gastric and Esophageal Adenocarcinoma (PARAMUNE)",
"has_exemption": false,
"start_date": "2024-06-24",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06470763",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06470763",
"title": "A First-in-human, Open-label, Multicenter Phase I/II Study to Evaluate the Safety and Anti-tumor Activity of ANV600 As Single Agent and in Combination with Pembrolizumab in Participants with Advanced Solid Tumors (EXPAND-1)",
"has_exemption": false,
"start_date": "2024-07-01",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Anaveon AG",
"sponsor_slug": "anaveon-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06736860",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06736860",
"title": "Early and Precise Application and Evaluation of Tranexamic Acid in Patients With Traumatic Bleeding Based on Dynamic Monitoring of Thromboelastography",
"has_exemption": false,
"start_date": "2024-08-01",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nanfang Hospital, Southern Medical University",
"sponsor_slug": "nanfang-hospital-southern-medical-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06268665",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06268665",
"title": "A Randomized Trial of Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy",
"has_exemption": false,
"start_date": "2024-08-15",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eve Rodler",
"sponsor_slug": "eve-rodler",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06179888",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06179888",
"title": "Randomized Phase 2 Study of Iberdomide Maintenance Therapy Following Idecabtagene Vicleucel CAR-T in Multiple Myeloma Patients",
"has_exemption": false,
"start_date": "2024-08-27",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06588413",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06588413",
"title": "Randomized, Double-Blind Study of FOND (Fosaprepitant, ONdansetron, Dexamethasone) Plus Either Olanzapine 2.5 mg Versus 5 mg for the Prevention of Chemotherapy Induced Nausea and Vomiting in Patients Receiving High-dose Melphalan Conditioning: The FONDO-LOW Study",
"has_exemption": false,
"start_date": "2024-09-17",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Augusta University",
"sponsor_slug": "augusta-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06681922",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06681922",
"title": "A Phase I-II Study of High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Abatacept for the Prevention of Graft-Versus-Host Disease (GVHD) Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)",
"has_exemption": false,
"start_date": "2024-09-23",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwell Health",
"sponsor_slug": "northwell-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06529731",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06529731",
"title": "A Phase 2 Trial of Interferon-γ (IFN-γ) in Combination With Donor Leukocyte Infusion (DLI) to Treat Relapsed Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) After Allogeneic Hematopoietic Stem Cell Transplantation (alloSCT)",
"has_exemption": false,
"start_date": "2024-09-23",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sawa Ito, MD",
"sponsor_slug": "sawa-ito-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06458439",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06458439",
"title": "Phase IIa Trial to Evaluate Epcoritamab Administered Before and After CAR-T Cell Therapy in Patients With Relapsed or Refractory Large B-cell Lymphomas",
"has_exemption": false,
"start_date": "2024-09-24",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Abramson Cancer Center at Penn Medicine",
"sponsor_slug": "abramson-cancer-center-at-penn-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06643312",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06643312",
"title": "Tethered Pelvic Assist Device for Recovery of Standing After Severe SCI",
"has_exemption": false,
"start_date": "2024-10-22",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kessler Foundation",
"sponsor_slug": "kessler-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06511141",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06511141",
"title": "Sacral Neuromodulation for Male Overactive Bladder",
"has_exemption": false,
"start_date": "2024-10-22",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Axonics, Inc.",
"sponsor_slug": "axonics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06651567",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06651567",
"title": "A Multicenter, Randomized, Double-blind, Placebo-controlled, Flexible-dose Study of the Efficacy, Safety, and Tolerability of ITI-1284 in Patients With Agitation Associated With Alzheimer's Dementia",
"has_exemption": false,
"start_date": "2024-10-22",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Intra-Cellular Therapies, Inc.",
"sponsor_slug": "intra-cellular-therapies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06483009",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06483009",
"title": "Efficacy and Safety of Combination Therapy of Sintilimab and Chemotherapy With Cryoablation in the First-Line Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2024-10-31",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Shanghai Chest Hospital",
"sponsor_slug": "shanghai-chest-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06637501",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06637501",
"title": "A Multicenter, Open-Label, Phase 2 Study to Investigate the Efficacy and Safety of Sonrotoclax Combined With Zanubrutinib Compared With Zanubrutinib Monotherapy in Adult Patients With Previously Untreated Chronic Lymphocytic Leukemia",
"has_exemption": false,
"start_date": "2024-11-14",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "BeiGene",
"sponsor_slug": "beigene",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06690775",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06690775",
"title": "Catalina-2: A Phase 2 Study Evaluating the Efficacy and Safety of TORL-1-23 in Women With Advanced Platinum-Resistant Epithelial Ovarian Cancer (Including Primary Peritoneal and Fallopian Tube Cancers) Expressing Claudin 6",
"has_exemption": false,
"start_date": "2024-11-20",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "TORL Biotherapeutics, LLC",
"sponsor_slug": "torl-biotherapeutics-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06634069",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06634069",
"title": "A Pilot, Randomized, Double-Blinded, Controlled Study of Hemodynamic and Acid Base Effects of 0.5M Sodium Lactate and 3% Saline Solutions in Septic Shock Patients",
"has_exemption": false,
"start_date": "2024-11-24",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University Hospital Pilsen",
"sponsor_slug": "university-hospital-pilsen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06609889",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06609889",
"title": "A Phase 1/2 Open Label Study to Evaluate the Safety and Efficacy of Intrathecally Administered ION283 in Patients With Lafora Disease",
"has_exemption": false,
"start_date": "2024-12-03",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Berge Minassian",
"sponsor_slug": "berge-minassian",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06568783",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06568783",
"title": "Evaluation of Patients With Refractory Dermatomyositis Using [18F]- Fibroblast Activation Protein Inhibitor-74 (FAPI-74) PET/MRI Imaging",
"has_exemption": false,
"start_date": "2024-12-31",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Farshad Moradi",
"sponsor_slug": "farshad-moradi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06192615",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06192615",
"title": "Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II)",
"has_exemption": false,
"start_date": "2025-01-06",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06782555",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06782555",
"title": "A Phase 1/2 Immunotherapy Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab in Patients with Advanced Solid Malignancies",
"has_exemption": false,
"start_date": "2025-01-08",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ImmunoGenesis",
"sponsor_slug": "immunogenesis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06721572",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06721572",
"title": "Role of Home-Based Transcutaneous Electrical Acustimulation for Treatment of Pain in Patients With Chronic Pancreatitis (TEA-CuP): A Double-Blind, Sham-Controlled Crossover Trial",
"has_exemption": false,
"start_date": "2025-01-13",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06555003",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06555003",
"title": "Comparative Analysis of the Efficacy of Irinotecan-loaded Drug-eluting Beads (DEBIRI) in Combination With Systemic Chemotherapy Versus Chemotherapy Alone in Unresectable Colorectal Cancer Liver Metastases: a Randomized Clinical Trial",
"has_exemption": false,
"start_date": "2025-01-20",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Tehran University of Medical Sciences",
"sponsor_slug": "tehran-university-of-medical-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06689085",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06689085",
"title": "Open-Label, Multiple-Dose, 52-Week Study to Evaluate the Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Deficiency or Absence of Endogenous Testosterone Due to Primary or Secondary Hypogonadism",
"has_exemption": false,
"start_date": "2025-02-05",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Halozyme Therapeutics",
"sponsor_slug": "halozyme-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06630845",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06630845",
"title": "Comparison of Whole Body DWI to FDG PET Using PET/MRI",
"has_exemption": false,
"start_date": "2025-02-06",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06617923",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06617923",
"title": "A Phase 2 Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer",
"has_exemption": false,
"start_date": "2025-02-06",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06561152",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06561152",
"title": "Tagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123-Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)",
"has_exemption": false,
"start_date": "2025-02-10",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06603662",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06603662",
"title": "Systemic Oral Glucocorticoids for the Treatment of Acute Osteoarthritis Pain in the Emergency Department",
"has_exemption": false,
"start_date": "2025-02-24",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "WellSpan Health",
"sponsor_slug": "wellspan-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06610825",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06610825",
"title": "A Phase II Clinical Trial to Evaluate the Efficacy and Safety of Fam-Trastuzumab Deruxtecan-Nxki (T-DXd) as a Subsequent Line of Therapy in HER2-Positive Metastatic Castration-Resistant Prostate Adenocarcinoma",
"has_exemption": false,
"start_date": "2025-03-05",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington D.C. Veterans Affairs Medical Center",
"sponsor_slug": "washington-dc-veterans-affairs-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06601296",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06601296",
"title": "STING Agonist and Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer (SPARK)",
"has_exemption": false,
"start_date": "2025-04-01",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06910787",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06910787",
"title": "Outpatient Virtual Reality-Directed Treatment for Pain in Inflammatory Bowel Disease",
"has_exemption": false,
"start_date": "2025-04-29",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06963034",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06963034",
"title": "A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NBI-1117568 in Adults With Schizophrenia Who Warrant Inpatient Hospitalization",
"has_exemption": false,
"start_date": "2025-05-08",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Neurocrine Biosciences",
"sponsor_slug": "neurocrine-biosciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06692686",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06692686",
"title": "The Development of Patient-Centered Clinical AFO Prescription Guidelines to Optimize Post-Stroke Function and Quality of Life",
"has_exemption": false,
"start_date": "2025-05-31",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas at Austin",
"sponsor_slug": "university-of-texas-at-austin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06665997",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06665997",
"title": "Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease",
"has_exemption": false,
"start_date": "2025-06-26",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06935591",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06935591",
"title": "Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study",
"has_exemption": false,
"start_date": "2025-06-27",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vektor Medical",
"sponsor_slug": "vektor-medical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04231708",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04231708",
"title": "Effects of Pharmacological Stress and Repetitive Transcranial Magnetic Stimulation Interventions on Executive Function in Opioid Use Disorder",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Wayne State University",
"sponsor_slug": "wayne-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06904235",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06904235",
"title": "A Multicentre, Multinational, Pharmacokinetic, Safety, and Efficacy Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC). A 2-part Study With Phase 2, Open-label, Randomised, Single-dose IV NEPA vs Fosaprepitant/Ondansetron in Single-day HEC and Repeated-dose IV NEPA in Multi-day HEC (Part I, Single Cycle) and With Phase 3, Double-blind, Randomised, Repeated-dose IV NEPA vs Fosaprepitant/Ondansetron in Multi-day HEC (Part II, Repeated Cycles)",
"has_exemption": false,
"start_date": "2025-07-07",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Helsinn Healthcare SA",
"sponsor_slug": "helsinn-healthcare-sa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06565390",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06565390",
"title": "Remote Oximeter Monitoring Post-discharge to Reduce Emergency Room Visits and Rehospitalization (ROMPER): A Randomized Clinical Trial",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06923488",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06923488",
"title": "Phase I/II Study of Leflunomide in Combination With Decitabine for Treatment of Relapsed or Refractory (R/R) Myelodysplastic Syndromes (MDS)",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "West Virginia University",
"sponsor_slug": "west-virginia-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04266275",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04266275",
"title": "An Investigation in the Use of Curcumin Topical Herbal Agent for the Treatment of Cervical Intraepithelial Neoplasia",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Lisa Flowers",
"sponsor_slug": "lisa-flowers",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06785272",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06785272",
"title": "Magnesium Trial in Acute Asthma in Emergency Department",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The Hospital for Sick Children",
"sponsor_slug": "the-hospital-for-sick-children",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07092566",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07092566",
"title": "Efficacy of Ropivacaine Epinephrine Clonidine Ketorolac (R.E.C.K) vs Exparel in Robotic Nephrectomy: a Randomized, Prospective Trial",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07096843",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07096843",
"title": "A Phase 2, Open-Label Study to Evaluate the Safety and Efficacy of Budoprutug (TNT119) in Subjects With Primary Membranous Nephropathy (PMN)",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Climb Bio, Inc.",
"sponsor_slug": "climb-bio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06712433",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06712433",
"title": "Bacterial Decolonization Plus Intraoperative Indocyanine Green Angiography for Soft Tissue Sarcomas of the Lower Extremity Receiving Preoperative Radiotherapy (CONCERTO)",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Adam Olson",
"sponsor_slug": "adam-olson",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06675435",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06675435",
"title": "The Effect of Inhaled Nitric Oxide on Intrapulmonary Shunt in Acutely Hypoxemic Patients With Severe Obesity",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06990945",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06990945",
"title": "Clinical Performance And Radiographic Assessment Of Mesoporous Bioactive Glass Adhesive Vs. Universal Adhesive In Class II Carious Lesions",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Cairo University",
"sponsor_slug": "cairo-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07018713",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07018713",
"title": "A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter, Clinical Trial With Extension Period to Evaluate the Efficacy and Safety of Xeomin® Injections for the Prevention of Chronic Migraine",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Merz Therapeutics GmbH",
"sponsor_slug": "merz-therapeutics-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07096726",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07096726",
"title": "Boston Medical Center Ultrasound Decongestion Study",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Boston Medical Center",
"sponsor_slug": "boston-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06226662",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06226662",
"title": "A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of NM8074 in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV)",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "NovelMed Therapeutics",
"sponsor_slug": "novelmed-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06652841",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06652841",
"title": "Prospective, Multi-center, Single Arm Feasibility Study of the transShield Embolic Protection System",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "TransAortic Medical, Inc.",
"sponsor_slug": "transaortic-medical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04862663",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04862663",
"title": "A Phase Ib/III, Open-label, Randomised Study of Capivasertib Plus CDK4/6 Inhibitors and Fulvestrant Versus CDK4/6 Inhibitors and Fulvestrant in Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced, Unresectable or Metastatic Breast Cancer (CAPItello-292)",
"has_exemption": false,
"start_date": "2021-05-10",
"completion_date": "2027-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05393180",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05393180",
"title": "Hybrid Convergent of Epicardial and Endocardial RF Ablation for the Treatment of Symptomatic Longstanding Persistent AF",
"has_exemption": false,
"start_date": "2022-04-13",
"completion_date": "2027-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "AtriCure, Inc.",
"sponsor_slug": "atricure-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05628779",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05628779",
"title": "Evaluation of the Safety, Efficacy and Cost-effectiveness of Transcatheter Tricuspid Valve Repair in Patients With Severe Tricuspid Regurgitation in the Netherlands.",
"has_exemption": false,
"start_date": "2022-12-12",
"completion_date": "2027-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Antonius Hospital",
"sponsor_slug": "st-antonius-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05687266",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05687266",
"title": "A Phase III, Randomised, Open-label, Multicentre, Global Study of Datopotamab Deruxtecan (Dato-DXd) in Combination With Durvalumab and Carboplatin Versus Pembrolizumab in Combination With Platinum-based Chemotherapy for the First-line Treatment of Patients With Locally Advanced or Metastatic NSCLC Without Actionable Genomic Alterations (D926NC00001; AVANZAR)",
"has_exemption": false,
"start_date": "2022-12-29",
"completion_date": "2027-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05723588",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05723588",
"title": "Neuroimaging Correlates and Feasibility of Transcranial Magnetic Stimulation (TMS) to Improve Smoking Cessation Outcomes in Veterans With Comorbid PTSD",
"has_exemption": false,
"start_date": "2023-10-31",
"completion_date": "2027-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06161532",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06161532",
"title": "A Phase II Study of Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile Cancer",
"has_exemption": false,
"start_date": "2024-08-01",
"completion_date": "2027-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06465953",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06465953",
"title": "A Phase 3, Multicenter, Open Label, Randomized, Non-comparative Two-arm Study of Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Adult Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an Isocitrate Dehydrogenase-1 (IDH1) Mutation (PyramIDH Study)",
"has_exemption": false,
"start_date": "2024-12-03",
"completion_date": "2027-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Institut de Recherches Internationales Servier",
"sponsor_slug": "institut-de-recherches-internationales-servier",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06706921",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06706921",
"title": "Usefulness of Tumor Heterogeneity Assessment in Patients With MCRPC Undergoing Radioligand Therapy With 177LU-PSMA-617 Using Serial 18F-DCFPYL, 18F-FDG and 18F-Fluciclovine PET/CT Predicting Clinical Outcome",
"has_exemption": false,
"start_date": "2024-12-15",
"completion_date": "2027-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Greater Los Angeles Healthcare System",
"sponsor_slug": "va-greater-los-angeles-healthcare-system",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06455527",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06455527",
"title": "HRV-Guided tDCS: Integrating A Biomarker For Clinical Utility",
"has_exemption": false,
"start_date": "2025-01-02",
"completion_date": "2027-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06357676",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06357676",
"title": "A Phase Ib/II Study Evaluating the Clinical Activity of Glofitamab Plus Ibrutinib (GLIB) With Obinutuzumab Pretreatment in Previously Untreated Mantle Cell Lymphoma in Patients ≥ 65 or Ages 18-64 With High-Risk Features",
"has_exemption": false,
"start_date": "2025-05-09",
"completion_date": "2027-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "OHSU Knight Cancer Institute",
"sponsor_slug": "ohsu-knight-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07017322",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07017322",
"title": "Investigating Non-invasive Cranial Electrotherapy Stimulation for Acute Anxiety in Inpatients With Eating Disorders",
"has_exemption": false,
"start_date": "2025-06-03",
"completion_date": "2027-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Rogers Behavioral Health",
"sponsor_slug": "rogers-behavioral-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06807437",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06807437",
"title": "A Randomized Phase III Blinded Trial of Lanreotide for the Prevention of Postoperative Pancreatic Fistula",
"has_exemption": false,
"start_date": "2025-06-28",
"completion_date": "2027-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03595683",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03595683",
"title": "Phase II Dual-Cohort Study Evaluating the Effects of Pembrolizumab in the Presence of Gut Microbiota Modulation With EDP1503 in Advanced Melanoma Naïve or Refractory to Anti-PD1 Antibody",
"has_exemption": false,
"start_date": "2018-10-02",
"completion_date": "2027-11-02",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06750289",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06750289",
"title": "BRISOTE: A Multicentre, Randomised, Double-Blind, Parallel Group, Active-Controlled, Phase 3b Study to Evaluate the Efficacy and Safety of Benralizumab 30 mg SC in Eosinophilic Asthma Patients Uncontrolled on Medium-Dose Inhaled Corticosteroid Plus Long-acting β2-Agonist.",
"has_exemption": false,
"start_date": "2025-03-28",
"completion_date": "2027-11-02",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07062965",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07062965",
"title": "An Interventional, Open-Label, Randomized, Multicenter, Phase 3 Study of PF-07248144 Plus Fulvestrant Compared to Investigator's Choice of Therapy in Adult Participants With Hormone Receptor-Positive, HER2-Negative Advanced/Metastatic Breast Cancer Whose Disease Progressed After Prior CDK4/6 Inhibitor-based Therapy",
"has_exemption": false,
"start_date": "2025-07-07",
"completion_date": "2027-11-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05551793",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05551793",
"title": "Dupilumab in the Treatment of Alopecia Areata Patients With an Atopic Background and/or High IgE",
"has_exemption": false,
"start_date": "2023-04-10",
"completion_date": "2027-11-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Emma Guttman",
"sponsor_slug": "emma-guttman",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06784999",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06784999",
"title": "Randomized Prospective Study Comparing Sufentanil Infusion vs Intravenous Methadone for Postoperative Analgesia Following Head and Neck Dissection With Free Flap or Rotational Reconstruction",
"has_exemption": false,
"start_date": "2025-01-10",
"completion_date": "2027-11-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Indiana University",
"sponsor_slug": "indiana-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07054515",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07054515",
"title": "18-month Double-blind, Randomized, Placebo-controlled, Multicenter, Phase 3 Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease and in Late-infantile and Juvenile-onset Forms of GM1 Gangliosidosis or GM2 Gangliosidosis",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2027-11-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Azafaros A.G.",
"sponsor_slug": "azafaros-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07082543",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07082543",
"title": "18-month Double-blind, Randomized, Placebo-controlled, Multicenter, Phase 3 Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease and in Late-infantile and Juvenile-onset Forms of GM1 Gangliosidosis or GM2 Gangliosidosis",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2027-11-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Azafaros A.G.",
"sponsor_slug": "azafaros-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07082725",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07082725",
"title": "18-month Double-blind, Randomized, Placebo-controlled, Multicenter, Phase 3 Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease and in Late-infantile and Juvenile-onset Forms of GM1 Gangliosidosis or GM2 Gangliosidosis",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2027-11-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Azafaros A.G.",
"sponsor_slug": "azafaros-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06508749",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06508749",
"title": "Phase I/II Trial to Evaluate the Impact of Three Broadly Neutralizing Antibodies or Analytic Treatment Interruption on Viral Reservoir, Immune Function, and Maintenance of HIV Suppression in Early Treated Children in Botswana",
"has_exemption": false,
"start_date": "2024-11-11",
"completion_date": "2027-11-05",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06813911",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06813911",
"title": "A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Atherosclerotic Cardiovascular Disease (ASCVD), and Elevated LDL-C and Lp(a)",
"has_exemption": false,
"start_date": "2025-04-30",
"completion_date": "2027-11-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06780787",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06780787",
"title": "Phase II Clinical Trial of FOLFOX, Botensilimab, Plus Balstilimab in Patients With Localized Rectal Cancer",
"has_exemption": false,
"start_date": "2025-05-20",
"completion_date": "2027-11-05",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07082738",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07082738",
"title": "A Multicentre, Parallel-group, Phase IIb, Randomised, Double-blind, Placebo-controlled, 4-Arm, 24-Week Study to Evaluate the Efficacy and Safety of AZD6793 Tablets in Adult Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (PRESTO)",
"has_exemption": false,
"start_date": "2025-06-27",
"completion_date": "2027-11-05",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07007962",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07007962",
"title": "A Multi-center, Open-label, Single-arm Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment",
"has_exemption": false,
"start_date": "2025-07-21",
"completion_date": "2027-11-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06570798",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06570798",
"title": "A Phase 2a, Open Label, Multicenter, Platform Trial to Assess the Safety, Tolerability, and Efficacy of Inebilizumab and Blinatumomab in Subjects With Autoimmune Diseases",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2027-11-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03077841",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03077841",
"title": "Optimizing Preventative Adjuvant Linac-Based Radiation: The OPAL Trial a Phase II/III Study of Hypofractionated Partial Breast Irradiation in Women With Early Stage Breast Cancer",
"has_exemption": false,
"start_date": "2017-03-06",
"completion_date": "2027-11-08",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05064878",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05064878",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Examine The Efficacy And Safety Of ZX008 In Subjects With CDKL5 Deficiency Disorder Followed By An Open-Label Extension",
"has_exemption": false,
"start_date": "2022-03-08",
"completion_date": "2027-11-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Zogenix, Inc.",
"sponsor_slug": "zogenix-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06990880",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06990880",
"title": "A Phase 1/2 First-Time-In-Human, Open-Label, Multicenter, Dose Escalation and Expansion Study of GSK5458514 PSMA Targeting T Cell Engager Alone or in Combination With Other Anti-Cancer Agents in Adult Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)",
"has_exemption": false,
"start_date": "2025-06-12",
"completion_date": "2027-11-09",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06546670",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06546670",
"title": "A Phase I/II Clinical Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of ITU512 in Healthy Participants and Patients With Sickle Cell Disease",
"has_exemption": false,
"start_date": "2024-08-15",
"completion_date": "2027-11-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06323980",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06323980",
"title": "Randomized, Prospective, Multi-Center Study of the INHANCE Stemless Total Reverse Shoulder System",
"has_exemption": false,
"start_date": "2025-03-04",
"completion_date": "2027-11-10",
"has_results": false,
"results_due": false,
"sponsor_name": "DePuy Orthopaedics",
"sponsor_slug": "depuy-orthopaedics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05265169",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05265169",
"title": "Ablation With Confirmation of Colorectal Liver Metastases (ACCLAIM) Prospective Trial for Microwave Ablation as a Local Cure",
"has_exemption": false,
"start_date": "2023-01-13",
"completion_date": "2027-11-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Society of Interventional Oncology",
"sponsor_slug": "society-of-interventional-oncology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05133440",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05133440",
"title": "SAXON-PC: A Phase II Randomized Trial of Stereotactic Body Radiation Therapy (SBRT) And Radium (Ra-223) Dichloride for Oligorecurrent, Non-castrate Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2021-11-12",
"completion_date": "2027-11-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06411158",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06411158",
"title": "Training for Urinary Leakage Improvement After Pregnancy",
"has_exemption": false,
"start_date": "2024-11-12",
"completion_date": "2027-11-12",
"has_results": false,
"results_due": false,
"sponsor_name": "NICHD Pelvic Floor Disorders Network",
"sponsor_slug": "nichd-pelvic-floor-disorders-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06928363",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06928363",
"title": "A First-in-human, Multicenter, Open-label Phase I/II Investigational Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of KY-0301 as Monotherapy in Patients With Advanced Solid Tumors.",
"has_exemption": false,
"start_date": "2025-05-01",
"completion_date": "2027-11-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Novatim Immune Therapeutics (Zhejiang) Co., Ltd.",
"sponsor_slug": "novatim-immune-therapeutics-zhejiang-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06159166",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06159166",
"title": "A Phase 1/2a Open-label, Multicenter Dose Finding Study to Evaluate the Safety and Anti-tumor Activity of Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF).",
"has_exemption": false,
"start_date": "2024-02-12",
"completion_date": "2027-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06602453",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06602453",
"title": "A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of GDC-8264 in Preventing Cardiac Surgery-Associated Acute Kidney Injury and Major Adverse Kidney Events",
"has_exemption": false,
"start_date": "2025-01-17",
"completion_date": "2027-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Genentech, Inc.",
"sponsor_slug": "genentech-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06952478",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06952478",
"title": "A Double-Blind, Randomized, Active-Controlled, Parallel-group, Phase 1/3 Study to Compare Pharmacokinetics, Efficacy and Safety of Subcutaneous CT-P44 and Darzalex Faspro in Combination With Lenalidomide and Dexamethasone in Patients With Refractory or Relapsed Multiple Myeloma",
"has_exemption": false,
"start_date": "2025-07-20",
"completion_date": "2027-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Celltrion",
"sponsor_slug": "celltrion",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06953583",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06953583",
"title": "A Phase 3, 2-Part, Randomized, Double-Blind, Placebo-Controlled Study (Part 1) and Open-Label Extension (Part 2) to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Omaveloxolone (BIIB141) in Participants With Friedreich's Ataxia Aged 2 to < 16 Years",
"has_exemption": false,
"start_date": "2025-06-09",
"completion_date": "2027-11-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Biogen",
"sponsor_slug": "biogen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06991257",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06991257",
"title": "A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF AN ORAL BRANCHED-CHAIN KETOACID DEHYDROGENASE KINASE INHIBITOR, PF-07328948, IN ADULTS WITH HEART FAILURE (BRANCH-HF)",
"has_exemption": false,
"start_date": "2025-06-19",
"completion_date": "2027-11-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04471727",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04471727",
"title": "A Phase 1/2 Open-label, Multicenter, Dose Escalation and Dose Expansion Study of the Safety, Tolerability, and Pharmacokinetics of HPN328 Monotherapy and HPN328 With Atezolizumab or Ifinatamab Deruxtecan (I-DXd) in Patients With Advanced Cancers Associated With Expression of Delta-like Canonical Notch Ligand 3 (DLL3).",
"has_exemption": false,
"start_date": "2020-12-14",
"completion_date": "2027-11-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)",
"sponsor_slug": "harpoon-therapeutics-inc-a-subsidiary-of-merck-co-inc-rahway-new-jersey-usa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02363296",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02363296",
"title": "Influence on Plasticity of Brain Temperature",
"has_exemption": false,
"start_date": "2016-05-03",
"completion_date": "2027-11-18",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Mental Health (NIMH)",
"sponsor_slug": "national-institute-of-mental-health-nimh",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04068649",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04068649",
"title": "A Phase 2 Randomized Study With a Non-randomized Cohort : Assessing Single-Fraction SBRT Versus Standard Palliative Radiation in Patients With Metastatic Disease (ASTEROID)",
"has_exemption": false,
"start_date": "2019-11-18",
"completion_date": "2027-11-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Roswell Park Cancer Institute",
"sponsor_slug": "roswell-park-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05497804",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05497804",
"title": "REsponse Adapted Combination Therapy Approaches for High-Risk Multiple Myeloma (REACH)",
"has_exemption": false,
"start_date": "2022-09-22",
"completion_date": "2027-11-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06567015",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06567015",
"title": "Phase I/II First-In-Human Open-label Trial to Assess Safety and Efficacy of STX-241 in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Resistant to EGFR Tyrosine Kinase Inhibitors (TKIs).",
"has_exemption": false,
"start_date": "2024-09-17",
"completion_date": "2027-11-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Pierre Fabre Medicament",
"sponsor_slug": "pierre-fabre-medicament",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05357092",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05357092",
"title": "Evaluation of Presurgical Orthopedics in Patients With Cleft Lip and/or Palate, a Randomized Controlled Clinial Trial.",
"has_exemption": false,
"start_date": "2025-11-21",
"completion_date": "2027-11-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Universidad Complutense de Madrid",
"sponsor_slug": "universidad-complutense-de-madrid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06698796",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06698796",
"title": "A PHASE 3, MULTI-CENTER, OPEN-LABEL EXTENSION STUDY TO INVESTIGATE THE LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF DAZUKIBART IN PARTICIPANTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES (INCLUDING PARTICIPANTS WITH DERMATOMYOSITIS OR POLYMYOSITIS)",
"has_exemption": false,
"start_date": "2025-01-22",
"completion_date": "2027-11-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03331198",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03331198",
"title": "An Open-Label, Phase 1/2 Study of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (017004)",
"has_exemption": false,
"start_date": "2017-11-27",
"completion_date": "2027-11-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Juno Therapeutics, a Subsidiary of Celgene",
"sponsor_slug": "juno-therapeutics-a-subsidiary-of-celgene",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06701656",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06701656",
"title": "Phase 2 Clinical Platform Trial Investigating Multiple Therapeutic Options for the Treatment of Hospitalized Patients With Acute Respiratory Distress Syndrome (ARDS)",
"has_exemption": false,
"start_date": "2025-02-26",
"completion_date": "2027-11-26",
"has_results": false,
"results_due": false,
"sponsor_name": "PPD DEVELOPMENT, LP",
"sponsor_slug": "ppd-development-lp",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06701669",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06701669",
"title": "Phase 2 Clinical Platform Trial Investigating Multiple Therapeutic Options for the Treatment of Hospitalized Patients With Acute Respiratory Distress Syndrome (ARDS)",
"has_exemption": false,
"start_date": "2025-06-10",
"completion_date": "2027-11-26",
"has_results": false,
"results_due": false,
"sponsor_name": "PPD DEVELOPMENT, LP",
"sponsor_slug": "ppd-development-lp",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06703073",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06703073",
"title": "Phase 2 Clinical Platform Trial Investigating Multiple Therapeutic Options for the Treatment of Hospitalized Patients With Acute Respiratory Distress Syndrome (ARDS)",
"has_exemption": false,
"start_date": "2025-06-10",
"completion_date": "2027-11-26",
"has_results": false,
"results_due": false,
"sponsor_name": "PPD DEVELOPMENT, LP",
"sponsor_slug": "ppd-development-lp",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06701682",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06701682",
"title": "Phase 2 Clinical Platform Trial Investigating Multiple Therapeutic Options for the Treatment of Hospitalized Patients With Acute Respiratory Distress Syndrome (ARDS)",
"has_exemption": false,
"start_date": "2025-06-21",
"completion_date": "2027-11-26",
"has_results": false,
"results_due": false,
"sponsor_name": "PPD DEVELOPMENT, LP",
"sponsor_slug": "ppd-development-lp",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06797518",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06797518",
"title": "A Multicenter, Single Arm, Open Label Biopsy Study to Evaluate Structural and Functional Changes in Kidneys of Adult Patients With IgA Nephropathy Receiving Iptacopan on Top of Supportive Care",
"has_exemption": false,
"start_date": "2025-02-21",
"completion_date": "2027-11-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06084338",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06084338",
"title": "Phase II Trial of Targeted Radiation With no Castration for Mcrpc",
"has_exemption": false,
"start_date": "2023-12-14",
"completion_date": "2027-11-29",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06541704",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06541704",
"title": "A Multicenter, Randomized, Double-Masked, Placebo-Controlled Phase 3 Study of the Efficacy, Safety, and Tolerability of Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration",
"has_exemption": false,
"start_date": "2024-10-30",
"completion_date": "2027-11-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02352883",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02352883",
"title": "Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)",
"has_exemption": false,
"start_date": "2015-03-25",
"completion_date": "2027-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03554083",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03554083",
"title": "Neoadjuvant Therapy for Patients With High Risk Stage III Melanoma: A Pilot Clinical Trial",
"has_exemption": false,
"start_date": "2018-10-05",
"completion_date": "2027-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04151940",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04151940",
"title": "An Interventional Study of PET/CT Changes During Chemoimmunotherapy and Radiation Therapy for Patients With Metastatic NSCLC (PET Bright)",
"has_exemption": false,
"start_date": "2019-09-26",
"completion_date": "2027-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04170283",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04170283",
"title": "An Open-label, Multi-center, Long-term Extension Study of Zanubrutinib (BGB-3111) Regimens in Patients With B-cell Malignancies",
"has_exemption": false,
"start_date": "2020-01-21",
"completion_date": "2027-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "BeiGene",
"sponsor_slug": "beigene",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04219254",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04219254",
"title": "A Phase 1/2a Clinical Trial of BI-1206, a Monoclonal Antibody to CD32b (FcγRIIB), in Combination with Pembrolizumab in Subjects with Advanced Solid Tumors Previously Treated with Anti-PD-1 or Anti-PD-L1 Antibodies (KEYNOTE-A04)",
"has_exemption": false,
"start_date": "2020-06-29",
"completion_date": "2027-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "BioInvent International AB",
"sponsor_slug": "bioinvent-international-ab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04802759",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04802759",
"title": "A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Breast Cancer (MORPHEUS-BREAST CANCER)",
"has_exemption": false,
"start_date": "2021-06-22",
"completion_date": "2027-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05026866",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05026866",
"title": "A Study of Donanemab Versus Placebo in Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease",
"has_exemption": false,
"start_date": "2021-08-27",
"completion_date": "2027-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05603572",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05603572",
"title": "A Multi-center, Open-label, Phase 1/2a Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of KAT-101 in Subjects With HCC",
"has_exemption": false,
"start_date": "2022-11-01",
"completion_date": "2027-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Primocure Pharma",
"sponsor_slug": "primocure-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05607420",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05607420",
"title": "Open-label Dose-finding and Dose-expansion Study to Evaluate the Safety, Expansion, Persistence, and Clinical Activity of UCART20x22 in Subjects with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (B-NHL)",
"has_exemption": false,
"start_date": "2022-11-01",
"completion_date": "2027-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Cellectis S.A.",
"sponsor_slug": "cellectis-sa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05278208",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05278208",
"title": "Phase I/II Study of Lutathera in Patients With Recurrent and/or Progressive High-Grade Central Nervous System Tumors and Meningiomas That Demonstrate Uptake on DOTATATE PET",
"has_exemption": false,
"start_date": "2022-11-21",
"completion_date": "2027-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Nationwide Children's Hospital",
"sponsor_slug": "nationwide-childrens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05757141",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05757141",
"title": "A Phase 1b/2 Open-label Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy Following Fosigotifator Administration in Adult and Pediatric Subjects With Vanishing White Matter Disease",
"has_exemption": false,
"start_date": "2023-03-13",
"completion_date": "2027-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04858256",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04858256",
"title": "Phase 2, Open Label, Multicenter Study of Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms",
"has_exemption": false,
"start_date": "2023-03-29",
"completion_date": "2027-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan Rogel Cancer Center",
"sponsor_slug": "university-of-michigan-rogel-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06082453",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06082453",
"title": "Modernizing Perinatal Syphilis Testing",
"has_exemption": false,
"start_date": "2023-05-02",
"completion_date": "2027-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05735717",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05735717",
"title": "Phase II, Open-Label, Prospective Study of T Cell Receptor Alpha/Beta Depletion (A/B TCD) Peripheral Blood Stem Cell (PBSC) Transplantation for Children and Adults With Hematological Malignancies",
"has_exemption": false,
"start_date": "2023-05-11",
"completion_date": "2027-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Masonic Cancer Center, University of Minnesota",
"sponsor_slug": "masonic-cancer-center-university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05889273",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05889273",
"title": "An Open-label Extension Study to Investigate Safety and Tolerability of ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD).",
"has_exemption": false,
"start_date": "2023-06-01",
"completion_date": "2027-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "MapLight Therapeutics",
"sponsor_slug": "maplight-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06043440",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06043440",
"title": "Randomized Control Trial of Oxygen Therapy in Children and Adolescents With Down Syndrome and Obstructive Sleep Apnea",
"has_exemption": false,
"start_date": "2023-10-24",
"completion_date": "2027-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05943535",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05943535",
"title": "A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)",
"has_exemption": false,
"start_date": "2023-10-30",
"completion_date": "2027-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "United Therapeutics",
"sponsor_slug": "united-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05852717",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05852717",
"title": "A Phase II Trial Evaluating Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma",
"has_exemption": false,
"start_date": "2023-10-31",
"completion_date": "2027-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Dipenkumar Modi",
"sponsor_slug": "dipenkumar-modi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06004115",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06004115",
"title": "Processes and Circuitry Underlying Threat Sensitivity as a Treatment Target for Co-morbid Anxiety and Depression",
"has_exemption": false,
"start_date": "2023-11-08",
"completion_date": "2027-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Laureate Institute for Brain Research, Inc.",
"sponsor_slug": "laureate-institute-for-brain-research-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05849038",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05849038",
"title": "The Role of Inflammation in Central Nervous System (CNS) Mechanisms of Anhedonia and Psychomotor Slowing in Depressed People With HIV",
"has_exemption": false,
"start_date": "2023-12-11",
"completion_date": "2027-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
}
]
}